7 articles tagged with #injective. AI-curated summaries with sentiment analysis and key takeaways from 50+ sources.
A pseudonymous security researcher has publicly accused Injective Protocol of offering an inadequate bounty payment and subsequently ghosting them after they disclosed a critical vulnerability that put $500 million at risk. The dispute highlights ongoing tensions between white hat hackers and DeFi protocols over appropriate bug bounty compensation.
Merkle Capital has launched Asia's first regulated fund focused on INJ (Injective), a blockchain platform for derivatives trading. This milestone signals growing institutional interest in regulated cryptocurrency products and could accelerate mainstream adoption of digital assets across the region, though market volatility and regulatory uncertainties remain risks.
Kevin O'Leary's keynote at a Zero-Knowledge Proofs conference has amplified discussions around AI-integrated cryptocurrencies in June 2026. Injective and Internet Computer are leading a significant market rally, with Injective up 73% in thirty days after breaking through consolidation, signaling sustained institutional and retail interest in AI-focused blockchain projects.
Injective has launched a governance proposal for its Vulcan mainnet upgrade, which aims to introduce new trading features and improve the protocol's efficiency. The upgrade could enhance tokenomics and increase $INJ's value while attracting additional users to the platform.
Circle's USDC stablecoin has launched natively on the Injective Network with Cross-Chain Transfer Protocol (CCTP) support, driving Circle's stock price up 2.83%. This integration enables secure cross-chain transfers and enhanced liquidity for USDC across different blockchain networks.
Injective Protocol will integrate native USDC support through Circle, enabling cross-chain transfers of the stablecoin. This integration will provide Injective traders and DeFi applications with a mainstream dollar-denominated asset for use as collateral, liquidity provision, and trade settlement.
Injective (INJ) recovered from a 95% decline with a 4500% rebound after finding support at a monthly order block. The cryptocurrency has broken its bearish structure and analysts have identified liquidity targets at $16, $35, and $53.
